Vitazi.ai
Vitazi.ai is a MedTech and Healthtech company pioneering Oculomics solutions for population-based, non-invasive screening and monitoring of chronic health conditions. Leveraging the retina as a window to overall health, their proprietary technology merges telehealth with a high-tech platform for retinal image capture, teleretinal screening by remote ophthalmologists, and medical image database integration. Their platform, which integrates with 93 EHR systems, aims to transform early disease detection and interception. Vitazi-MD™, their FDA-cleared solution, streamlines screening for systemic diseases like diabetic retinopathy at the point of care, helping providers meet quality measures and improve patient outcomes. Vitazi-DR™, an AI-driven add-on, accelerates diagnosis. The company operates at the intersection of data, AI, and teleretinal analysis to provide cost-effective, primary, population-based solutions for systemic health screening, with applications in cardiovascular disease, neurodegenerative disorders, and cancer.
Vitazi.ai
Vitazi.ai is a MedTech and Healthtech company pioneering Oculomics solutions for population-based, non-invasive screening and monitoring of chronic health conditions. Leveraging the retina as a window to overall health, their proprietary technology merges telehealth with a high-tech platform for retinal image capture, teleretinal screening by remote ophthalmologists, and medical image database integration. Their platform, which integrates with 93 EHR systems, aims to transform early disease detection and interception. Vitazi-MD™, their FDA-cleared solution, streamlines screening for systemic diseases like diabetic retinopathy at the point of care, helping providers meet quality measures and improve patient outcomes. Vitazi-DR™, an AI-driven add-on, accelerates diagnosis. The company operates at the intersection of data, AI, and teleretinal analysis to provide cost-effective, primary, population-based solutions for systemic health screening, with applications in cardiovascular disease, neurodegenerative disorders, and cancer.
TL;DR
Headquarters: Santa Fe, New Mexico
Product: Vitazi‑MD (FDA‑cleared) and Vitazi Insights (cloud oculomics)
Focus: AI-powered retinal imaging and teleretinal screening for systemic and ocular disease
Founders: Jeremy Stueven, MD, MBA; co-founder Alan Nolley, Jr., JD
Employees: 11
Seed round closed Feb 14, 2025; total reported funding $2,150,000 (USD)